KORTNEY SPANN: Open Payments
NPI 1023525490 · LITTLE ROCK, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$910 in 41 payments from 12 companies in 2025. Trend: 2023 $74 · 2024 $333 · 2025 $910
Food & beverage: $910
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 11 | $174 |
| Minerva Surgical, Inc | 1 | $133 |
| Astellas Pharma US Inc | 5 | $122 |
| Biogen, Inc. | 6 | $121 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $102 |
| MAYNE PHARMA COMMERCIAL LLC | 5 | $60 |
| LSI SOLUTIONS INC | 1 | $58 |
| SHIELD THERAPEUTICS INC | 2 | $44 |
| Exeltis, USA Inc. | 2 | $37 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $28 |
Products named: MYFEMBREE, Veozah, ZURZUVAE, Mirena, FORNISEE, ACCRUFER, SLYND, VPRIV.
Industry payments across AR — which companies pay providers there.
